World Health Organization reports on CBD safety

enfleur-blog-world-health-organization-cbd.png
ENFLEUR 1000mg Broad Spectrum Cannabinoids
Quick View
ENFLEUR 1000mg Broad Spectrum Cannabinoids
65.00
Quantity:
Add To Cart
ENFLEUR 1000mg Full Spectrum Cannabinoids
Quick View
ENFLEUR 1000mg Full Spectrum Cannabinoids
65.00
Quantity:
Add To Cart

Ahead of US federal policy, earlier this year the WHO released a report on cannabidiol (CBD) that found that it was not only medicinally beneficial, but is safe for humans and animals and “not associated with abuse potential”. This is because, unlike its fellow phytocannabinoid THC, CBD is non-psychoactive. This means that CBD is not able to induce intoxication and in spite of the US’s classification of CBD as a Schedule I controlled substance, it is not associated with any abuse potential. The WHO report noted CBD’s anti-epileptic, anti-inflammatory, analgesic, neuro-protective, hypoxia-ischemia, anxiolytic, antipsychotic, anti-asthmatic, and anti-tumor properties, as well as preliminary findings suggesting CBD’s potential therapeutic application in addiction treatment.